Wadsworth Veterans Affairs Hospital, Los Angeles, California 90073
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Peptides release histamine from enterochromaffin-like (ECL)
cells because of elevation of intracellular Ca2+
concentration ([Ca2+]i) by either
receptor-operated or voltage-dependent Ca2+ channels
(VDCC). To determine whether VDCCs contribute to histamine release
stimulated by gastrin or pituitary adenylate cyclase-activating polypeptide (PACAP), the presence of VDCCs and their possible modulation by peptides was investigated in a 48-h cultured rat gastric
cell population containing 85% ECL cells. Video imaging of fura
2-loaded cells was used to measure
[Ca2+]i, and histamine was assayed
by RIA. Cells were depolarized by increasing extracellular
K+ concentrations or by 20 mM
tetraethylammonium (TEA+). Cell depolarization increased
transient and steady-state [Ca2+]i
and resulted in histamine release, dependent on extracellular Ca2+. These K+- or TEA+-dependent
effects on histamine release from ECL cells were coupled to activation
of parietal cells in intact rabbit gastric glands, and L-type channel
blockade by 2 µM nifedipine inhibited 50% of [Ca2+]i elevation and histamine
release. N-type channel blockade by 1 µM -conotoxin GVIA inhibited
25% of [Ca2+]i elevation and 14%
of histamine release. Inhibition was additive. The effects of 20 mM
TEA+ were fully inhibited by 2 µM nifedipine. Both
classes of Ca2+ channels were found in ECL cells, but not
in parietal cells, by RT-PCR. Nifedipine reduced PACAP-induced (but not
gastrin-stimulated) Ca2+ entry and histamine release by
40%. Somatostatin, peptide YY (PYY), and galanin dose
dependently inhibited L-type Ca2+ channels via a pertussis
toxin-sensitive pathway. L-type VDCCs play a role in PACAP but not
gastrin stimulation of histamine release from ECL cells, and the
channel opening is inhibited by somatostatin, PYY, and galanin by
interaction with a Gi or Go protein.
acid secretion; gastric glands; calcium channels
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
CALCIUM CHANNELS in neuroendocrine cells are important
because Ca2+ entry through these channels controls a wide
variety of their physiological functions, such as transmitter release,
firing patterns, biochemical processes, bioenergetics, and gene
expression (28). The three types of known Ca2+
entry pathways are voltage-dependent Ca2+ channels (VDCC),
receptor-operated Ca2+ channels (ROCC), and reversal of
Na+/Ca2+ exchange (21, 28, 38, 42). VDCCs are
expressed in excitable neurons, muscle cells, and all neuroendocrine
cells so far studied, such as hypothalamic, pituitary, glomus corticum,
thyroid C, neuroendocrine pulmonary, chromaffin, enterochromaffin,
CCK-secreting, and pancreatic - and
-cells (28).
Distinct types of VDCCs have been defined according to various
pharmacological and electrophysiological criteria: L-type channels are
dihydropyridine sensitive, whereas N-type channels are -conotoxin GVIA (
-CTx-GVIA) sensitive. P- and Q-type channels are distinguished on the basis of differential sensitivities to
-agatoxin IVA, and the
R-type component of the high-voltage-activated current is resistant
to dihydropyridines and toxins (28, 54). Cloning has shown an even
greater diversity among VDCCs. At least six different genes have been
identified, and even greater functional diversity might be produced by
alternative splicing of the different gene products (28, 54). These
channels differ considerably in their responsiveness to
neuromodulators, their distribution among various cell types, and their
localization in different regions within individual cells (9, 14, 35).
There is now general agreement that, even in a single cell, different
subtypes of VDCCs can be coexpressed (9, 14, 35).
The enterochromaffin-like (ECL) cell is a histamine-containing neuroendocrine cell in fundic gastric mucosa that plays a central role in the peripheral regulation of mammalian gastric acid secretion (19, 20, 52). Studies using a preparation of isolated, highly enriched ECL cells have shown that these cells display some of the characteristic features of neuroendocrine cells, but their stimulus-secretion coupling is often like that of nonexcitable cells such as the mast cell (3, 34, 47). Activation of histamine secretion requires specific signaling dependent on a distinct receptor distribution on ECL cells (32, 47, 48, 52, 61). ECL cells respond to the antral hormone gastrin with histamine secretion, activation of the histamine-synthesizing enzyme histidine decarboxylase (HDC), and cellular proliferation (49). Other stimulatory receptors such as pituitary adenylate cyclase-activating polypeptide (PACAP), adrenergic, and cytokine receptors have been found, as well as inhibitory receptors such as somatostatin, galanin, and peptide YY (PYY) receptors (59-62). Although several studies clearly indicate that an intracellular Ca2+ concentration ([Ca2+]i)-dependent pathway is required for histamine release, the specific cellular mechanisms that regulate histamine release have yet to be delineated (47, 61).
Electrophysiological studies have shown that the ECL cell has a resting
potential of 58 mV, and pharmacological studies demonstrate that
L-type Ca2+ channels are the main VDCCs presented in rat
ECL cells (3, 34). L-type Ca2+ channels are believed to
contribute to exocytosis in many neuroendocrine cells, such as insulin
secretion from pancreatic
-cells (34), catecholamines from
chromaffin cells (14, 30, 33, 35, 50), 5-HT from enterochromaffin cells
(59), and many other cell types (9-11, 27, 39). However, whether
L-type Ca2+ channels contribute to activation of secretion
of histamine from rat ECL cells is not known. In the present study,
this issue was addressed by RT-PCR to analyze the expression of L-type
Ca2+ channels and by video imaging to monitor single cell
[Ca2+ ]i responses. Contributions
of the distinct Ca2+ channel subtypes to the release of
histamine measured by RIA were evaluated by using L- and N-type
antagonists after cell depolarization by high K+ or by
tetraethylammonium (TEA+). In addition, we also
investigated whether L-type Ca2+ channels are functionally
altered by gastrin and neuropeptides such as PACAP, PYY, somatostatin,
and galanin and whether histamine release from ECL cells induced by
depolarization affects parietal cells in intact gastric gland preparations.
We found that high-K+ solution induced dose-related histamine release from rat ECL cells and H2 histamine-receptor antagonist-sensitive Ca2+ signals in rabbit glands. L-type VDCCs were found to be the main contributors, accounting for 50% of K+ depolarization and 95% of TEA+-induced histamine release. L-type Ca2+ channels also contribute 40% of the PACAP-induced Ca2+ entry signal, as well as histamine release, but are probably not involved in gastrin-induced Ca2+ entry and histamine release (<10%). In ECL cells, L-type Ca2+ channels are completely inhibited by somatostatin, galanin, and PYY.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Isolation and purification of ECL cells. The rat gastric ECL cells were isolated by a combination of elutriation and density gradient centrifugation as described previously (47, 61). Five rat stomachs provided 1 × 106 small cells in the low-density layer. Cell viability was >95% as determined by trypan blue exclusion. Cell purification was quantified by immunostaining with anti-HDC antibody and antihistamine antibody and by using the fluorescent dye acridine orange, which accumulates with a red shift in fluorescence in the acidic, histamine-containing vacuoles. A majority (65-75%) of cells in the freshly isolated cell population were ECL cells. Freshly isolated ECL cells were rinsed by gentle centrifugation in growth medium containing DMEM/F-12, supplemented with 2 mg/ml BSA, 2.5% FCS, 100 µM hydrocortisone, 1% penicillin, streptomycin, and 5 mg/ml insulin, 5 mg/ml transferrin, and 5 µg/l sodium selenite. After 48 h in culture, the ECL cell population was enriched to >85%. All Ca2+ imaging experiments and histamine release studies were carried out on these cultured cells after 2-4 days in culture at 37°C.
RT-PCR analysis of dihydropyridine- and
-CTx-GVIA-sensitive
Ca2+ channels.
Molecular cloning and heterologous expression systems have shown that
the different
1-subunits give rise to Ca2+ channels that
reflect the electrophysiological and pharmacological classification.
The
1C- and
1D-subunits produce L-type
Ca2+ currents that are sensitive to dihydropyridines, and
the
1B-subunit produces an N-type Ca2+
channel that is sensitive to
-CTx-GVIA. The
1A-subunit expresses a
-agatoxin-IVA-sensitive
current resembling both P- and Q-type Ca2+ channels,
possibly differentiated by alternative splicing of the
1A-subunit transcript or by association with different
auxiliary subunits. The
1E-subunit encodes for a
Ca2+ channel characterized by voltage activation properties
at relatively negative potentials, fast kinetics, and insensitivity to
known toxins or drugs. Whether the
1E-subunit represents
the R-type or other types of Ca2+ currents remains to be determined.
|
Measurement of [Ca2+]i in isolated cells using video microscopy. After 48-h culture, cells were loaded with 2 µM fura 2-AM for 30 min at 37°C, and then the coverslip was washed with growth medium and placed in a heated chamber (Medical Systems, Greenvale, NY). The temperature was maintained constant at 37°C. The coverslip was perfused with Ringer buffer with different concentrations of KCl or TEA+ at a rate of 5 ml/min, and the effluent was constantly removed with a peristaltic pump. Fura 2 fluorescence was measured by using a Nikon Fluo ×40 objective with a Zeiss Axiovert 100TV microscope (Zeiss, Thornwood, NY) connected to a PC-XT computer programmed to rapidly alternate between the excitation wavelengths of 340 and 380 nm. The emission wavelength (505 nm) was constant. Image pairs were captured under the control of Image-1/FL software (Universal Imaging, West Chester, PA) and expressed as the ratio of fluorescence level in the chosen field. Maximal and minimal fluorescence was achieved by adding 10 µM ionomycin followed by 20 mM EGTA. [Ca2+]i was calculated using previously described formulas with slight modification (47, 61). All data presented in the Figs. 1-10 are representative of at least four experiments.
Confocal microscopy of rabbit gastric glands. The preparation of rabbit fundic gastric glands and measurement of [Ca2+]i by confocal microscopy are the same as described elsewhere (N. Zeng, unpublished observations). Briefly, under anesthesia, high-pressure aortic perfusion with mammalian Ringer was used to loosen the epithelial layer from the submucosa. The stomach was removed, and the epithelium was stripped off, minced with scissors, and digested with collagenase. The glands are washed by allowing them to settle on the coverslips and then kept at room temperature until use. This is a preparation that responds to histamine, gastrin, and carbachol in terms of stimulation of acid secretion and changes of intracellular messengers in the parietal cells. Furthermore, as in humans, gastrin stimulation but not carbachol stimulation of acid secretion is ablated by H2-receptor antagonists. Hence, rabbit glands were chosen as an integrated model in which to investigate the action of high-K+ depolarization on ECL cells in situ and consequent effects on parietal cells. It was expected that the ECL cell of rabbit has a generally similar response to that of rat, and this expectation is borne out by our experiments.
The glands were loaded with fluo 4-AM at a concentration of 5 µM for 30 min on a coverslip coated with Cell-TAK before they were transferred to a superfusion chamber at 37°C. The dye fluorescence was measured at 525 nm, with excitation at 488 nm. The high-K+ solutions (40 mM) were added during the perfusion with Ringer buffer as noted. The relative changes in [Ca2+]i were monitored on a selected region during the experiment, visualizing individual gastric glands at ×63 magnification, scanning 512 × 512 pixels every other second. The region of interest was highlighted on the image, with numbers indicating the position of each image on the scan. Changes in Ca2+ in ECL cells and parietal cells were measured. The images are representative of at least four experiments.Histamine release. Histamine release was determined following 48-h culture by incubating ECL cells on Cell-TAK-precoated coverslips in six-well plates. Growth medium was replaced 3 h before the experiments. The cultured ECL cells were rinsed with Ringer buffer and incubated in test medium for 60 min at 37°C. Approximately 20,000 cells per well were seeded for the experiment. The test medium contained, as necessary, different concentrations of K+ or TEA+ in Ringer medium. Na+ was replaced by K+ or TEA+, retaining the same osmolarity in different test solutions. Histamine concentrations were determined as previously described by using a commercially available kit (AMAC, Westbrook, MA). The data are presented as percent over basal (control).
Statistical analysis. Results are means ± SE. Where appropriate, statistical analysis of the data was performed by Mann-Whitney U test if the Kruskali-Willis indicated a significant difference between multiple groups. For multiple comparisons with the same control group, the limit of significance was divided by the number of comparisons according to Bonferroni. Differences between paired groups were determined using a paired t-test. Median effective concentration and IC50 were calculated by using linear regression analysis. Values were considered statistically significant when P < 0.05.
Materials.
Rabbit anti-HDC antibody and monoclonal antibody against somatostatin
(S6) were obtained from the Antibody Core of the CURE Digestive
Diseases Research Center. All other reagents were analytical grade and
were purchased from the indicated sources. Pronase E was from
Boehringer Mannheim. Taq+ DNA polymerase and
pCR-Script Amp SK(+) plasmid were from Stratagene (La Jolla, CA). PCR
primers for -actin were from Clontech (Palo Alto, CA). Model 391 PCR-MATE ABI was from Perkin-Elmer (Foster City, CA). Gastrin-17 and
galanin were from Peninsula. PACAP-27 was from American Peptide. BSA,
acridine orange, DMEM/F-12, insulin-transferrin-sodium selenite media
supplement, hydrocortisone, trypan blue, gastrin, somatostatin, goat anti-rabbit fluorescein-conjugated IgG, ionomycin, TEA, and EGTA were all from Sigma; Cell-TAK was from Collaborative Research; Nycodenz was from Accurate Chemical (Westbury, NY); and fura
2 was from Molecular Probes (Eugene, OR).
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Selective expression of dihydropyridine- and
-CTx-GVIA-sensitive
Ca2+ channels on ECL cells.
For analysis of dihydropyridine- and
-CTx-GVIA-sensitive
Ca2+ channel expression by RT-PCR, 5 µg total RNA
extracted from purified rat ECL or parietal cells was used to make
cDNAs as described previously using RT. The same amount of cDNA from
purified ECL cells and parietal cells was used for PCR and
amplification of HDC; H+-K+-ATPase and
-actin were used as internal controls.
|
K+ depolarization induced
elevation of
[Ca2+]i.
Elevation of extracellular K+ concentration depolarizes
cells because of changes in the K+ equilibrium potential.
To determine whether VDCCs are involved in the Ca2+ entry
in ECL cells, fura 2-loaded ECL cells were perfused with HEPES buffer
containing from 5 (basal) to 60 mM K+ that substituted for
Na+. In the presence of Ringer buffer containing 5 mM
extracellular K+, the resting
[Ca2+]i in ECL cells was found to
be from 70 to 146 nM and remained unchanged for up to 3-5 h at
37°C as described previously (61). Brief exposure (1 min)
to elevated extracellular K+ from 5 (basal) to 10, 20, 40, and 60 mM resulted in a rapid (peak in 5-10 s) transient increase
in [Ca2+]i that fell rapidly, as
shown in Fig. 2A. With prolonged
exposure to an increase in K+, for example 40 mM, a typical
biphasic [Ca2+]i increase was found
in >85% of the cells observed as an initial transient followed by a
plateau phase (Fig. 2B), reminiscent of the gastrin or PACAP
response of the ECL cells. Some cells even had a sustained
[Ca2+]i increase when the
K+ concentration was <20 mM (data not shown).
|
|
|
High-K+ solution- and TEA+-induced histamine release requires external Ca2+. To determine the functional effect of high-K+ and TEA+ depolarization on isolated gastric ECL cells, the release of histamine from ECL cells was examined after exposure to different concentrations of KCl and TEA+.
Under basal conditions, cultured ECL cells release 40 pmol histamine per well. In the presence of 1.8 mM Ca2+ in the incubation medium, K+ depolarization elevated histamine release from cultured ECL cells in a dose-related manner, with maximal release being 500% of basal at 40 mM (Fig. 5A). Addition of TEA+ to the incubation medium induced a dose-dependent increase in histamine release, with a maximal threefold increase at 30 mM (Fig. 5B). Increasing TEA+ to 40 mM did not increase the histamine release further. The minimum effective dose of TEA+ was 10 mM, and the EC50 was 20 mM. However, in Ca2+-deficient medium, high-K+ depolarization- and TEA+-induced histamine release were completely abolished (Fig. 5C). These results suggested that K+ depolarization- and TEA+-induced histamine release from ECL cells depended on Ca2+ entry from the extracellular space.
|
Effects of high-K+
depolarization on rabbit gastric glands.
As shown in Fig. 6, ECL cells load with the
fluo 4 dye to a greater extent than parietal cells, presumably because
of accumulation of the dye in the secretory vacuoles. In the confocal
microscope, only single-plane sections are shown here, visualizing only
a single ECL cell but several parietal cells, reflecting the relative numbers of these two cell types. The scan of a defined region of the
images in the whole sequence shows the Ca2+ signal in a
specific cell type.
|
Contribution of L-type Ca2+ channels to high K+- and TEA+-induced Ca2+ entry. K+ depolarization induces Ca2+ entry via VDCCs in many types of neuroendocrine cells. VDCCs have been classified into at least six types (L, N, P, Q, T, and O) on the basis of electrophysiological and pharmacological criteria. Multiple brief applications of 40 mM K+ (1 min) produce [Ca2+]i transients of identical amplitude, as described. Therefore, we pulsed KCl to examine the pharmacology of subtypes of VDCCs in ECL cells.
L-type channel blockade by 2 µM nifedipine inhibited 50% of [Ca2+]i elevation (Fig. 7A) and histamine release (Fig. 7B). N-type channel blockade by 1 µM
|
Modulation of L-type Ca2+
channels by peptide ligands.
Gastrin and PACAP showed the same efficacy in stimulation of histamine
release, namely a fourfold increase over basal from isolated rat ECL
cells (49, 59). As shown in Fig. 8, both gastrin (109 M) and PACAP
(10
9 M) stimulated a biphasic
Ca2+ signal. Nifedipine gave <10% inhibition on
gastrin-induced Ca2+ entry and histamine release (Fig.
8A). However, nifedipine partially inhibited the PACAP-induced
Ca2+ transient and 40% of the PACAP-induced histamine
release (Fig. 8B). Part of the action of PACAP is via
modulation of other Ca2+ pathways.
|
|
Modulation of G proteins in VDCCs.
The inhibitory effects of somatostatin, galanin, and PYY on
gastrin-induced Ca2+ entry and histamine release are
sensitive to pertussis toxin, indicating that these neuropeptide
receptors are coupled to Gi or Go proteins (12,
23, 25, 26, 37). Pretreatment of the cultured ECL cells with pertussis
toxin (200 ng/ml) for 16 h abolished the inhibitory action of
somatostatin and PYY on both Ca2+ signaling
and histamine release and partially reduced the inhibition by galanin,
as shown in Fig. 10.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Some neuroendocrine cells share characteristics with neuronal cells, such as their secretory mechanisms, membrane trafficking proteins, and electrical excitability (11, 28, 52, 58). Some neuroendocrine cells can fire action potentials in response to membrane depolarization (11, 28, 52, 58). The depolarization-induced action potentials cause corresponding rises in [Ca2+]i and thereby Ca2+-dependent hormone or transmitter release (11). The Ca2+ influx due to membrane depolarization occurs mainly by voltage-dependent Ca2+ channels in neurons as well as in most types of neuroendocrine cells.
A rise in [Ca2+]i is an obligatory step in stimulus-secretion coupling in ECL cells due to gastrin or PACAP (47, 52, 61). The ECL cells produce and store histamine (19, 20). This biogenic amine is stored in vesicles with a total content of 2.8-4.3 pg/cell of histamine, which is a relatively low amount compared with mast cells (12-20 pg/cell). The cytoplasm of ECL cells shows numerous hollow vesicles, which contain histamine, and a characteristic electron-dense core inside these electron-lucent vesicles, which is thought to represent the storage of a peptide hormone (19, 20). The exocytotic process of histamine release involves members of membrane-trafficking protein families such as vesicle-associated membrane protein, synaptosome-associated protein, or syntaxins (24). In isolated rat ECL cells, the removal of extracellular Ca2+ abolishes the secretion of histamine in response to gastrin, showing that influx of Ca2+ into the ECL cell is required for histamine release (47, 61). Patch-clamp analysis has shown the presence of voltage-gated Ca2+ currents in rat gastric ECL cells, inhibited by verapamil and augmented by the L-type Ca2+ channel activator BAY K 8644 (3), but their functional significance was not analyzed.
Excitation-secretion coupling in many endocrine cells is dependent on
changes in membrane voltage, which is controlled by ion channels (57,
58). Modulation of ion channels causes changes in resting membrane
potential that lead to alteration in Ca2+ influx and
hormone secretion. In most endocrine cells, the resting membrane
voltage is regulated by K+ channels (57, 58). ECL cells
have a resting potential of 58 mV. Electrophysiological and
pharmacological studies have provided evidence for
depolarization-activated K+ channels and Ca2+
channels in gastric ECL cells (3). It has been established that
K+ channels are important modulators of hormone secretion
in many types of endocrine cells (3, 34). Blocking K+
channels induces catecholamine release from adrenal medullary cells,
corticoid secretion from adrenocortical cells, insulin secretion from
pancreatic
-cells, and prolactin secretion from pituitary cells (4,
17, 57).
In this study, we confirmed that L- and N-type Ca2+ channels are selectively expressed in the gastric ECL cells by measurements of Ca2+ signals and RT-PCR. In addition, we found that Ca2+ influx through L-type VDCCs induced increases in [Ca2+]i and exocytosis in gastric ECL cells.
First, both high-K+ and TEA+ depolarization-induced histamine release depended on external Ca2+ and were partially or completely inhibited by nifedipine, respectively, at the concentrations that target L-type channels. Second, BAY K 8644 significantly enhanced the depolarization-induced histamine release. BAY K 8644 alone also induced a biphasic Ca2+ signal and histamine release from ECL cells, which was totally inhibited by nifedipine. Therefore, an L-type Ca2+ channel, as in other neuroendocrine cells, is present in ECL cells and may play a role in histamine release. This depolarization-induced Ca2+ elevation in isolated ECL cells is also found in intact rabbit gastric glands, and the subsequent [Ca2+]i response of the parietal cell in this integrated preparation shows that there is depolarization-dependent signaling between these two cell types, implying a physiological significance to the VDCCs found only in the ECL cell.
In the present study, we have also evaluated the effect of blocking K+ channels on histamine release from isolated gastric ECL cells by using the K+ channel blocker TEA+. We found that TEA+ (10-40 mM) evoked histamine release from cultured ECL cells. We have also shown that TEA+-induced histamine release is absolutely dependent on the presence of external Ca2+ and that this histamine release is completely blocked by nifedipine and profoundly enhanced by the L-type Ca2+ channel agonist BAY K 8644.
Gastrin is the major endocrine ligand that serves to stimulate
histamine secretion. This effect is mediated by the binding of gastrin
to CCK-B receptors located on the surface of the ECL cell, and
secretion can be detected within 5 min (52). The effect of binding the
ligand is displayed as a typical G7 receptor-mediated change in
[Ca2+]i, namely a transient
followed by a steady-state elevation. The elevation of Ca2+
during cellular activation by Ca2+-mobilizing hormones may
originate from both release from intracellular Ca2+ stores
and entry via membrane Ca2+ channels (61). Patch-clamp
experiments have shown that both L- and N-type VDCCs could be activated
during exocytosis because of electrical changes after fusion of the
histamine-containing vacuole with the plasma membrane of ECL cell (3).
The histamine-containing vacuole has a membrane V-type ATPase (VMAT2)
that is an electrogenic proton pump. Acidification by this pump depends
on the presence of a Cl conductance that allows
electrogenic proton pumping. Stimulation of histamine release by
gastrin resulted in activation of a Cl
current,
presumably because of fusion of the vacuole membrane with the plasma
membrane (34). The depolarization because of this channel could
activate VDCCs. However, our data show that the L-type
channel is not important in the gastrin-induced histamine release in
vitro because nifedipine had no effects on gastrin-induced Ca2+ entry and histamine release. Different results were
obtained for stimulation of ECL cells by PACAP.
We previously found that PAC1 receptors are expressed on gastric ECL
cells by using RT-PCR and by pharmacological studies measuring
Ca2+ signals and histamine release in isolated ECL cells
and gastric glands (59). Influx of Ca2+ through different
VDCCs has been reported to mediate PACAP-induced catecholamine release
from bovine chromaffin cells or insulin release from pancreatic islet
-cells (6, 15, 18, 40, 59). Here, activation of L-type VDCCs also
contributed to PACAP-induced Ca2+ entry and histamine
release because nifedipine significantly reduced histamine release as
well as Ca2+ entry induced by PACAP. It is of interest that
PACAP, in contrast to gastrin, is coupled to both adenylylcyclase and
Ca2+ elevation. Elsewhere, we have shown that PACAP
addition to rabbit gastric glands elevates ECL cell Ca2+
and also parietal cell Ca2+, the latter effect being
completely blocked by H2-receptor antagonists. Furthermore,
PACAP injection can result in gastric acid stimulation in intact rats,
provided the response of the fundic D cell is blunted by the presence
of neutralizing somatostatin antibody (60a). It appears that VDCCs may
play a role in PACAP activation of acid secretion.
There are many neuropeptides involved in the inhibition of ECL cell function (48, 60, 62). Somatostatin is known to be a major peptide inhibitor of gastric acid secretion with distinct cellular targets, such as the G cell of the antrum and the ECL cell of the fundus. In the case of the ECL cell, somatostatin, by binding at a somatostatin 2 subtype receptor, inhibits both histamine release and Ca2+ signaling. PYY is a peptide that also inhibits gastric acid secretion by acting at a variety of locations. Pharmacological evidence in the rat suggests that its site of action on the ECL cell is at a Y1 receptor of PYY. Interestingly, this peptide blocks the plateau phase of Ca2+ signaling but is much less active against the transient elevation of [Ca2+]i (23). The PYY effect may account for much of the inhibitory effect of nutrient presentation to the intestine, classified as an "enterogastrone" effect. Recently, we found that galanin has an equipotent effect to somatostatin in inhibition of ECL function (60).
In the -cell of the pancreas, somatostatin and galanin inhibit
insulin release by blockade of the L-type Ca2+ channels
(12, 22, 23, 25, 26, 29, 39, 41, 43, 44, 53, 56, 60). PYY is also
effective in inhibition of L-type Ca2+ channels in PC-12
cells and other neuroendocrine cell lines (55, 62). In our study, we
found that these peptides inhibit high-K+ and
TEA+ depolarization-induced Ca2+ signals and
histamine release as well as BAY K 8644-induced Ca2+
signals and histamine release, indicating that, in this cell type,
these inhibitory peptides are able to inhibit L-type Ca2+
channels. Their effects on TEA+- or BAY K 8644-induced
Ca2+ signals and histamine release were abolished by
pretreatment with pertussis toxin, similar to their effects on gastrin
stimulation of the ECL cell. Hence, inhibition of either VDCCs or ROCCs
of these inhibitory peptides is mediated by Gi trimeric
proteins (12, 22, 23, 26, 29, 39, 41, 53).
The importance of N-type Ca2+ channels in the stimulation of neuronal transmitter release has been well demonstrated, and numerous neurotransmitters have been found to inhibit transmitter release through inhibition of this channel subtype (9, 14, 30, 33). Our data indicate that N-type Ca2+ channels are expressed on ECL cells, but, functionally, they seem less important in stimulus secretion coupling than the L-type Ca2+ channels, similar to data obtained for catecholamine release from chromaffin cells (14, 30, 35).
In vivo studies have implied that VDCCs may be involved in the regulation of gastric acid secretion because nifedipine, an L-type Ca2+ channel antagonist, could significantly reduce gastric acid secretion in humans and rats (1, 2, 5, 8, 13, 16, 31, 36). This investigation therefore suggests that L-type Ca2+ channels, expressed on gastric ECL cells, are functionally coupled to histamine release induced by a neuropeptide, PACAP. Because this peptide elevates both cAMP and [Ca2+]i and gastrin is not coupled to adenylylcyclase, perhaps the cAMP component of PACAP signaling is coupled to activation of L-type Ca2+ channels (6, 7, 15, 18, 40, 46). On the other hand, other Ca2+ pathways are involved in ECL function, such as the stores and also the receptor-operated channels activated by gastrin binding to the CCK-B receptor. PAC 1 receptors are also coupled to this system, explaining why inhibitory peptides such as somatostatin are more effective inhibitors than L-type channel blockade.
This investigation shows that L-type Ca2+ channels are indeed expressed on gastric ECL cells and are coupled to histamine release activated by a neuropeptide, PACAP. The finding that activation of these L-type Ca2+ channels is blocked by somatostatin, galanin, and PYY is pertussis toxin sensitive is in agreement with our previous investigations into mechanisms of inhibition of ECL cell function by these neuropeptides. This study, in combination with our previous work, provides additional evidence that regulation of gastric acid secretion by neuropeptides from enteric neurons is exerted via regulation of ECL cell function, in part by activation of VDCCs.
![]() |
ACKNOWLEDGEMENTS |
---|
This work was supported by United States Veterans Affairs Senior Medical Investigation and National Institute of Diabetes and Digestive and Kidney Diseases Grants DK-46917, DK-53462, DK-41301, and DK-17294.
![]() |
FOOTNOTES |
---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: G. Sachs, Wadsworth VA Hospital, Los Angeles, CA 90073 (E-mail: gsachs{at}ucla.edu).
Received 3 June 1999; accepted in final form 18 August 1999.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Beil, W.,
R. J. Bersimbaev,
H. Hannemann,
and
K. F. Sewing.
Interaction of calcium channel antagonists with parietal cell acid production, adenylate cyclase, intracellular-free Ca2+ and H+/K+-ATPase.
Pharmacology
40:
8-20,
1990[Medline].
2.
Bouclier, M.,
and
M. Spedding.
Differential effects of calcium channel antagonists on histamine and pentagastrin-stimulated gastric acid secretion in the rat.
Agents Actions
16:
491-495,
1985[Medline].
3.
Bufler, J.,
G. C. Choi,
C. Franke,
W. Schepp,
and
C. Prinz.
Voltage-gated Ca2+ currents in rat gastric enterochromaffin-like cells.
Am. J. Physiol.
274 (Cell Physiol. 43):
C424-C429,
1998
4.
Cahill, A. L.,
and
R. L. Perlman.
Tetraethylammonium selectively stimulates secretion from noradrenergic bovine chromaffin cells.
J. Auton. Pharmacol.
14:
177-185,
1994[Medline].
5.
Caldara, R.,
E. Masci,
C. Barbieri,
M. Sorghi,
V. Piepoli,
and
A. Tittobello.
Effect of nifedipine on gastric acid secretion and gastrin release in healthy man.
Eur. J. Clin. Pharmacol.
28:
677-679,
1985[Medline].
6.
Chang, C. H.,
W. Y. Chey,
L. Braggins,
D. H. Coy,
and
T. M. Chang.
Pituitary adenylate cyclase-activating polypeptide stimulates cholecystokinin secretion in STC-1 cells.
Am. J. Physiol.
271 (Gastrointest. Liver Physiol. 34):
G516-G523,
1996
7.
Chatterjee, T. K.,
R. V. Sharma,
and
R. A. Fisher.
Molecular cloning of a novel variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor that stimulates calcium influx by activation of L-type calcium channels.
J. Biol. Chem.
271:
32226-32232,
1996
8.
Chew, C. S.
Differential effects of extracellular calcium removal and nonspecific effects of Ca2+ antagonists on acid secretory activity in isolated gastric glands.
Biochim. Biophys. Acta
846:
370-378,
1985[Medline].
9.
Clos, M. V.,
A. Garcia Sanz,
J. Sabria,
C. Pastor,
and
A. Badia.
Differential contribution of L- and N-type calcium channels on rat hippocampal acetylcholine release.
Neurosci. Lett.
182:
125-128,
1994[Medline].
10.
Cohen, C. J.,
and
R. T. McCarthy.
Nimodipine block of calcium channels in rat anterior pituitary cells.
J. Physiol. (Lond.)
387:
195-225,
1987[Abstract].
11.
Cui, Z. J.
Types of voltage-dependent calcium channels involved in high potassium depolarization-induced amylase secretion in the exocrine pancreatic tumour cell line AR4-2J.
Cell Res.
8:
23-31,
1998[Medline].
12.
Degtiar, V. E.,
B. Wittig,
G. Schultz,
and
F. Kalkbrenner.
A specific G(o) heterotrimer couples somatostatin receptors to voltage-gated calcium channels in RINm5F cells.
FEBS Lett.
380:
137-141,
1996[Medline].
13.
Erjavec, F.,
and
L. Stanovnik.
The effect of different calcium antagonists on histamine- and carbachol-induced acid secretion in the isolated mouse stomach.
Agents Actions
27:
163-165,
1989[Medline].
14.
Gandia, L.,
R. Borges,
A. Albillos,
and
A. G. Garcia.
Multiple calcium channel subtypes in isolated rat chromaffin cells.
Pflügers Arch.
430:
55-63,
1995[Medline].
15.
Geng, G.,
R. Gaspo,
F. Trabelsi,
and
N. Yamaguchi.
Role of L-type Ca2+ channel in PACAP-induced adrenal catecholamine release in vivo.
Am. J. Physiol.
273 (Regulatory Integrative Comp. Physiol. 42):
R1339-R1345,
1997
16.
Glavin, G. B.
Verapamil and nifedipine effects on gastric acid secretion and ulcer formation in rats.
J. Pharm. Pharmacol.
40:
514-515,
1988[Medline].
17.
Gonzalez-Garcia, C.,
V. Cena,
H. R. Keiser,
and
E. Rojas.
Catecholamine secretion induced by tetraethylammonium from cultured bovine adrenal chromaffin cells.
Biochim. Biophys. Acta
1177:
99-105,
1993[Medline].
18.
Hahm, S. H.,
C. M. Hsu,
and
L. E. Eiden.
PACAP activates calcium influx-dependent and -independent pathways to couple met-enkephalin secretion and biosynthesis in chromaffin cells.
J. Mol. Neurosci.
11:
43-56,
1998[Medline].
19.
Hakanson, R.,
C. Owman,
N. O. Sjoberg,
and
B. Sporrong.
Amine mechanisms in enterochromaffin and enterochromaffin-like cells of gastric mucosa in various mammals.
Histochemie
21:
189-220,
1970[Medline].
20.
Hakanson, R.,
and
F. Sundler.
Histamine-producing cells in the stomach and their role in the regulation of acid secretion.
Scand. J. Gastroenterol. Suppl.
180:
88-94,
1991[Medline].
21.
Hardie, R. C.
Calcium signalling: setting store by calcium channels.
Curr. Biol.
6:
1371-1373,
1996[Medline].
22.
Herlitze, S.,
D. E. Garcia,
K. Mackie,
B. Hille,
T. Scheuer,
and
W. A. Catterall.
Modulation of Ca2+ channels by G-protein subunits.
Nature
380:
258-262,
1996[Medline].
23.
Hescheler, J.,
and
G. Schultz.
Heterotrimeric G proteins involved in the modulation of voltage-dependent calcium channels of neuroendocrine cells.
Ann. NY Acad. Sci.
733:
306-312,
1994[Abstract].
24.
Hohne-Zell, B.,
A. Galler,
W. Schepp,
M. Gratzl,
and
C. Prinz.
Functional importance of synaptobrevin and SNAP-25 during exocytosis of histamine by rat gastric enterochromaffin-like cells.
Endocrinology
138:
5518-5526,
1997
25.
Homaidan, F. R.,
G. W. Sharp,
and
L. M. Nowak.
Galanin inhibits a dihydropyridine-sensitive Ca2+ current in the RINm5f cell line.
Proc. Natl. Acad. Sci. USA
88:
8744-8748,
1991[Abstract].
26.
Hsu, W. H.,
H. D. Xiang,
A. S. Rajan,
D. L. Kunze,
and
A. E. D. Boyd.
Somatostatin inhibits insulin secretion by a G-protein-mediated decrease in Ca2+ entry through voltage-dependent Ca2+ channels in the beta cell.
J. Biol. Chem.
266:
837-843,
1991
27.
Izumi, S.,
S. S. Stojilkovic,
and
K. J. Catt.
Calcium mobilization and influx during the biphasic cytosolic calcium and secretory responses in agonist-stimulated pituitary gonadotrophs.
Arch. Biochem. Biophys.
275:
410-428,
1989[Medline].
28.
Jones, S. W.
Overview of voltage-dependent calcium channels.
J. Bioenerg. Biomembr.
30:
299-312,
1998[Medline].
29.
Kalkbrenner, F.,
V. E. Degtiar,
M. Schenker,
S. Brendel,
A. Zobel,
J. Heschler,
B. Wittig,
and
G. Schultz.
Subunit composition of G(o) proteins functionally coupling galanin receptors to voltage-gated calcium channels.
EMBO J.
14:
4728-4737,
1995[Abstract].
30.
Kim, S. J.,
W. Lim,
and
J. Kim.
Contribution of L- and N-type calcium currents to exocytosis in rat adrenal medullary chromaffin cells.
Brain Res.
675:
289-296,
1995[Medline].
31.
Lazzaroni, M.,
M. Petrillo,
O. Sangaletti,
and
G. Bianchi Porro.
Effect of nifedipine on gastric acid secretion and gastrin release in man.
Hepatogastroenterology
33:
257-259,
1986[Medline].
32.
Lindstrom, E.,
M. Bjorkqvist,
A. Boketoft,
D. Chen,
C. M. Zhao,
K. Kimura,
and
R. Hakanson.
Neurohormonal regulation of histamine and pancreastatin secretion from isolated rat stomach ECL cells.
Regul. Pept.
71:
73-86,
1997[Medline].
33.
Lomax, R. B.,
P. Michelena,
L. Nunez,
J. Garcia-Sancho,
A. G. Garcia,
and
C. Montiel.
Different contributions of L- and Q-type Ca2+ channels to Ca2+ signals and secretion in chromaffin cell subtypes.
Am. J. Physiol.
272 (Cell Physiol. 41):
C476-C484,
1997
34.
Loo, D. D.,
G. Sachs,
and
C. Prinz.
Potassium and chloride currents in rat gastric enterochromaffin-like cells.
Am. J. Physiol.
270 (Endocrinol. Metab. 33):
E739-E745,
1996
35.
Lopez, M. G.,
A. Albillos,
M. T. de la Fuente,
R. Borges,
L. Gandia,
E. Carbone,
A. G. Garcia,
and
A. R. Artalejo.
Localized L-type calcium channels control exocytosis in cat chromaffin cells.
Pflügers Arch.
427:
348-354,
1994[Medline].
36.
McColl, K. E.,
N. M. Buchanan,
G. Laferla,
J. Hearns,
K. Buchanan,
and
G. P. Crean.
Effects of nifedipine on gastric acid secretion and gastrin release in man.
Gut
28:
455-459,
1987[Abstract].
37.
McCullough, L. A.,
T. M. Egan,
and
T. C. Westfall.
Neuropeptide Y inhibition of calcium channels in PC-12 pheochromocytoma cells.
Am. J. Physiol.
274 (Cell Physiol. 43):
C1290-C1297,
1998
38.
Mikoshiba, K.
The InsP3 receptor and intracellular Ca2+ signaling.
Curr. Opin. Neurobiol.
7:
339-345,
1997[Medline].
39.
Nussinovitch, I.
Somatostatin inhibits two types of voltage-activated calcium currents in rat growth-hormone secreting cells.
Brain Res.
504:
136-138,
1989[Medline].
40.
O'Farrell, M.,
and
P. D. Marley.
Multiple calcium channels are required for pituitary adenylate cyclase-activating polypeptide-induced catecholamine secretion from bovine cultured adrenal chromaffin cells.
Naunyn Schmiedebergs Arch. Pharmacol.
356:
536-542,
1997[Medline].
41.
Offermanns, S.,
M. Gollasch,
J. Hescheler,
K. Spicher,
A. Schmidt,
G. Schultz,
and
W. Rosenthal.
Inhibition of voltage-dependent Ca2+ currents and activation of pertussis toxin-sensitive G-proteins via muscarinic receptors in GH3 cells.
Mol. Endocrinol.
5:
995-1002,
1991[Abstract].
42.
Parekh, A. B.,
and
R. Penner.
Store depletion and calcium influx.
Physiol. Rev.
77:
901-930,
1997
43.
Parsons, R. L.,
and
L. M. Konopka.
Galanin-induced hyperpolarization of mudpuppy neurons is calcium dependent.
Neurosci. Lett.
115:
207-212,
1990[Medline].
44.
Parsons, R. L.,
J. M. Mulvaney,
and
L. A. Merriam.
Galanin activates an inwardly rectifying potassium conductance and inhibits a voltage-dependent calcium conductance in mudpuppy parasympathetic neurons.
Ann. NY Acad. Sci.
863:
156-169,
1998
45.
Perez-Reyes, E.,
X. Y. Wei,
A. Castellano,
and
L. Birnbaumer.
Molecular diversity of L-type calcium channels. Evidence for alternative splicing of the transcripts of three non-allelic genes.
J. Biol. Chem.
265:
20430-20436,
1990
46.
Perez-Reyes, E.,
W. Yuan,
X. Wei,
and
D. M. Bers.
Regulation of the cloned L-type cardiac calcium channel by cyclic-AMP-dependent protein kinase.
FEBS Lett.
342:
119-123,
1994[Medline].
47.
Prinz, C.,
M. Kajimura,
D. R. Scott,
F. Mercier,
H. F. Helander,
and
G. Sachs.
Histamine secretion from rat enterochromaffinlike cells.
Gastroenterology
105:
449-461,
1993[Medline].
48.
Prinz, C.,
G. Sachs,
J. H. Walsh,
D. H. Coy,
and
S. V. Wu.
The somatostatin receptor subtype on rat enterochromaffinlike cells.
Gastroenterology
107:
1067-1074,
1994[Medline].
49.
Prinz, C.,
D. R. Scott,
D. Hurwitz,
H. F. Helander,
and
G. Sachs.
Gastrin effects on isolated rat enterochromaffin-like cells in primary culture.
Am. J. Physiol.
267 (Gastrointest. Liver Physiol. 30):
G663-G675,
1994
50.
Racke, K.,
A. Reimann,
H. Schworer,
and
H. Kilbinger.
Regulation of 5-HT release from enterochromaffin cells.
Behav. Brain Res.
73:
83-87,
1996[Medline].
51.
Rich, A.,
and
J. L. Rae.
Calcium entry in rabbit corneal epithelial cells: evidence for a nonvoltage dependent pathway.
J. Membr. Biol.
144:
177-184,
1995[Medline].
52.
Sachs, G.,
N. Zeng,
and
C. Prinz.
Physiology of isolated gastric endocrine cells.
Annu. Rev. Physiol.
59:
243-256,
1997[Medline].
53.
Takano, K.,
J. Yasufuku-Takano,
A. Teramoto,
and
T. Fujita.
Gi3 mediates somatostatin-induced activation of an inwardly rectifying K+ current in human growth hormone-secreting adenoma cells.
Endocrinology
138:
2405-2409,
1997
54.
Tsien, R. W.,
P. T. Ellinor,
and
W. A. Horne.
Molecular diversity of voltage-dependent Ca2+ channels.
Trends Pharmacol. Sci.
12:
349-354,
1991[Medline].
55.
Walker, M. W.,
D. A. Ewald,
T. M. Perney,
and
R. J. Miller.
Neuropeptide Y modulates neurotransmitter release and Ca2+ currents in rat sensory neurons.
J. Neurosci.
8:
2438-2446,
1988[Abstract].
56.
Wang, J.,
Y. N. Kwok,
K. G. Baimbridge,
and
J. C. Brown.
Galanin inhibition of cholecystokinin-8-induced increase in [Ca2+]i in individual rat pancreatic B-cells.
Biochem. Biophys. Res. Commun.
182:
858-863,
1992[Medline].
57.
Wang, X.,
and
M. A. Greer.
Blocking K+ channels with TEA induces plasmalemma depolarization, increased [Ca2+]i, and ACTH secretion in AtT-20 cells.
Mol. Cell. Endocrinol.
109:
11-18,
1995[Medline].
58.
Wiser, O.,
M. Trus,
A. Hernandez,
E. Renstrom,
S. Barg,
P. Rorsman,
and
D. Atlas.
The voltage sensitive Lc-type Ca2+ channel is functionally coupled to the exocytotic machinery.
Proc. Natl. Acad. Sci. USA
96:
248-253,
1999
59.
Zeng, N.,
T. Kang,
R. M. Lyu,
H. Wong,
Y. Wen,
J. H. Walsh,
G. Sachs,
and
J. R. Pisegna.
The pituitary adenylate cyclase activating polypeptide type 1 receptor (PAC1-R) is expressed on gastric ECL cells: evidence by immunocytochemistry and RT-PCR.
Ann. NY Acad. Sci.
865:
147-156,
1998
60.
Zeng, N.,
T. Kang,
Y. Wen,
H. Wong,
J. Walsh,
and
G. Sachs.
Galanin inhibition of enterochromaffin-like cell function.
Gastroenterology
115:
330-339,
1998[Medline].
60a.
Zeng, N., C. A. Kang, H. Wong, J. H. Walsh, R. M. Lyu, G. V. Ohning, G. Sachs, and J. R. Pesigna. Role of PACAP 1 receptor in regulation of ECL cells and gastric acid secretion by
pituitary adenylate cyclase activating polypeptide (PACAP). J. Clin. Invest. In press.
61.
Zeng, N.,
J. H. Walsh,
T. Kang,
K. G. Helander,
H. F. Helander,
and
G. Sachs.
Selective ligand-induced intracellular calcium changes in a population of rat isolated gastric endocrine cells.
Gastroenterology
110:
1835-1846,
1996[Medline].
62.
Zeng, N.,
J. H. Walsh,
T. Kang,
S. V. Wu,
and
G. Sachs.
Peptide YY inhibition of rat gastric enterochromaffin-like cell function.
Gastroenterology
112:
127-135,
1997[Medline].